# Jefferies Financial Group Type: Company (JEF) Source: GetYourBrief — https://getyourbrief.com/entity/jefferies-financial-group Canonical HTML page: https://getyourbrief.com/entity/jefferies-financial-group ## Timeline - **2026-07-08**: Wells Fargo Cuts Target to $70 — Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside. - **2026-07-01**: Bank of America Lowers Target — Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating. - **2026-06-15**: Piper Sandler Stays Overweight — Piper Sandler reaffirms an Overweight rating on Freshpet shares. - **2026-06-01**: Weiss Ratings Downgrades — Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'. - **2026-05-07**: JPMorgan Upgrades, Others Reaffirm — JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target. - **2026-04-22**: Jefferies Cuts Target — Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating. - **2026-04-08**: TD Cowen Turns Bullish — TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective. - **2026-03-20**: Oppenheimer Upgrades Freshpet — Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target. ## Recent coverage (20 stories, network-wide) ### Morgan Stanley Cuts AMH PT to $38, Sees 11% Upside in SFR 2026-08-16 15:04:23 · Sector: proptech · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Single-family rental REIT American Homes 4 Rent has a modestly reduced $38 price target from Morgan Stanley, still above a $36.78 consensus and leaving 11% upside. The maintained Overweight rating reinforces the resilience of the SFR asset class amid housing supply constraints. Full story: https://getproptechbrief.com/story/morgan-stanley-amh-38-proptech-sfr ### Morgan Stanley Cuts AMH PT to $38; Consensus $36.78, 11% Upside 2026-08-16 15:04:14 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Morgan Stanley trimmed its American Homes 4 Rent target to $38 from $38.50 while keeping an Overweight rating, against a $36.78 consensus and Moderate Buy average. Equity research actions from Jefferies, UBS, RBC, Mizuho, and Compass Point reveal a broadly constructive but price-sensitive stance on the REIT. Full story: https://getfinancebrief.com/story/morgan-stanley-amh-price-target-38-finance ### SGP Hits $17.56 Low: 156% Upside to $45 Analyst Target 2026-08-10 05:23:16 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Spyglass Pharma's stock plunges to a new 52-week low of $17.56 despite a consensus 'Moderate Buy' rating and an average analyst target of $45. For biotech investors, the 156% upside potential must be weighed against a recent earnings miss and a downgrade to sell, raising questions about near-term pipeline catalysts. Full story: https://getbiobrief.com/story/spyglass-pharma-52-week-low-156-percent-upside-bio ### BARK's $0.48 EPS Beat: Subscription Pet Brand Soars 22.8% to $11.25 2026-08-09 00:42:18 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2 BARK's quarterly earnings impressed with $0.08 EPS, crushing the -$0.40 estimate on $78.81M revenue. The pet subscription company's stock jumped 22.8% as improving unit economics hint at a retail turnaround. Full story: https://getretailbrief.com/story/bark-retail-earnings-beat ### BARK Stock Surges 22.8% on $0.48 EPS Beat, Analysts Target $15.33 2026-08-09 00:42:10 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 BARK delivered a surprise $0.08 EPS, beating estimates by $0.48, sending its battered stock up to $11.25. With a $101.6M market cap and a consensus target of $15.33, the high-beta small-cap is drawing both institutional and retail interest. Full story: https://getfinancebrief.com/story/bark-finance-earnings-beat ### EPAM beats Q3 EPS estimates with $3.46 high-end, guides FY EPS to $13.24 2026-08-07 01:17:02 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 EPAM Systems' Q3 EPS guidance of up to $3.46 topped consensus by 3.9%, while full-year profit view surged to $13.24, handily beating the $12.53 consensus. Despite a flat revenue outlook, the firm's improved profitability signals strong cost controls and could spark a re-rating of its discounted stock, now trading at 15.7x earnings. Full story: https://getfinancebrief.com/story/epam-systems-q3-2026-guidance-beats-street ### CBRE Ups FY2026 EPS View to $7.80-$7.90 as Real Estate Tech Demand Booms 2026-08-05 14:17:03 · Sector: proptech · Sentiment: Neutral · Impact: 5/10 · Sources: 2 CBRE Group's above-consensus EPS guidance underscores the commercial real estate sector's momentum, driven by technology-driven services. For PropTech startups and investors, it signals growing client spending on smart buildings, data analytics, and digital brokerage platforms. Full story: https://getproptechbrief.com/story/cbre-fy2026-guidance-proptech ### Teva's $1.91-$2.11 EPS Guidance Misses Consensus, Testing Pharma Resilience 2026-08-05 14:16:51 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Teva Pharmaceutical's FY2026 EPS guidance fell short of the $2.17 consensus, while revenue projections of $16.5-$16.9B matched expectations. For healthcare leaders, the miss underscores ongoing generic drug pricing pressures and the importance of a diversified pipeline. Full story: https://gethealthbrief.com/story/teva-fy2026-guidance-health ### Teva's $1.91-$2.11 EPS Outlook Misses as Biotech Investors Weigh Risk-Reward 2026-08-05 14:16:40 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Teva's fiscal 2026 EPS guidance, well below the Street's $2.17, raises red flags for biotech and pharma investors. However, a $42 average price target and stable revenue suggest a value play if the biosimilar pipeline delivers. Full story: https://getbiobrief.com/story/teva-fy2026-guidance-biotech ### Bloom Energy Soars 6.5%: $310 Target in Play with 46% Volume Spike 2026-08-04 01:50:17 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Bloom Energy shares popped 6.5% on 46% higher volume to $219.22, reigniting the debate about its $62.36B valuation amid a bull-bear analyst divide. With price targets spanning $188 to $310 and a P/E near 292, the AI-driven stock offers high risk and high potential reward. Full story: https://getfinancebrief.com/story/bloom-energy-be-stock-surge-6-5-percent ### Bloom Energy 6.5% Jump: AI Data Centers Fuel $62B Clean Power Bet 2026-08-04 01:50:06 · Sector: climate · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Bloom Energy's 6.5% stock surge reflects market conviction that its fuel cells will power the AI data center boom. With a $62.36B market cap and raised annual guidance, the company is cementing itself as a critical clean energy infrastructure provider, but legal risks and high valuation loom. Full story: https://getclimatebrief.com/story/bloom-energy-ai-clean-power-surge ### Nayax Gaps Up 4.7% as Retail Payment Tech Draws $2.47B Valuation 2026-08-03 06:28:41 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Nayax shares jumped 4.7% on Monday after a series of analyst upgrades, despite a Q1 earnings miss. With a market cap of $2.47 billion and a rich P/E of 85, the cashless payment provider for unattended retail faces both secular tailwinds and profitability scrutiny. Consensus price target stands at $78.16, offering 15.9% upside. Full story: https://getretailbrief.com/story/nayax-gap-up-retail-payments-valuation ### TeraWulf (WULF) Surges 7% as Bitcoin Mining Stock Targets Hit $40 2026-08-03 06:28:30 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2 TeraWulf Inc. surged 7% on Monday to $19.43 after multiple analyst upgrades, even after a massive Q1 EPS miss. With a $9.45 billion market cap and a sky-high debt-to-equity ratio of 33, the Bitcoin miner’s stock is a pure play on crypto momentum, as consensus targets reach $34.60 and one analyst calls for $40. Full story: https://getcryptobrief.com/story/terawulf-wulf-surge-crypto-mining-stocks ### Wabtec FY26 EPS $10.60-$10.90, Moody's $16.50-$17.00: Both Miss Consensus 2026-07-23 02:24:25 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks. Full story: https://getfinancebrief.com/story/wabtec-moodys-fy26-guidance-analysis ### MCRI Beats Q2 EPS by $0.11; $2.21B Casino Stock Eyes $144 Target Amid Insider Sale 2026-07-21 01:35:47 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102. Full story: https://getfinancebrief.com/story/mcri-earnings-beat-011-eps-analyst-targets-insider-sale ### Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside 2026-07-09 13:12:08 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts. Full story: https://getfinancebrief.com/story/wells-fargo-cuts-freshpet-target-70-upside ### AI capex arms race pushes GDP to 5.9% but could drain startup funding 2026-06-21 10:53:16 · Sector: startups · Sentiment: Neutral · Impact: 7/10 · Sources: 2 While the AI infrastructure boom is driving U.S. economic growth to 5.9% nominal GDP, it’s also fueling inflation that could force the Fed to hike rates by 36bp. Higher borrowing costs may squeeze venture capital flows, but AI startups might still ride the spending wave. Full story: https://getstartupbrief.com/story/ai-spending-boom-startup-funding-rate-hikes ### 36bp of rate hikes by end-2026? AI spending blamed for sticky inflation 2026-06-21 10:53:10 · Sector: finance · Sentiment: Neutral · Impact: 7/10 · Sources: 2 A new Jefferies report warns that the massive AI infrastructure buildout is keeping U.S. inflation elevated, forcing markets to price in further rate hikes. Two-year Treasury yields just saw their biggest one-day jump in 14 months, and money markets now expect 36 basis points of tightening by year-end. Full story: https://getfinancebrief.com/story/ai-spending-inflation-fed-rate-hikes ### AI infrastructure spending now drives 5.9% US growth—and stokes inflation 2026-06-21 10:53:02 · Sector: ai · Sentiment: Neutral · Impact: 7/10 · Sources: 2 Jefferies’ latest research reveals that the AI capex arms race is the main engine behind 5.9% nominal GDP growth, but it is simultaneously pushing CPI to a three-year high. The sector’s breakneck buildout is reshaping monetary policy expectations and the funding landscape for AI ventures. Full story: https://getaibrief.com/story/ai-capex-inflation-economic-growth ### Zacks Issues Strong Sell Ratings for Fortescue and Kering Amid China Headwinds 2026-03-22 01:05:00 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Zacks Research has issued rare 'Strong Sell' ratings for both Australian mining giant Fortescue and French luxury conglomerate Kering. The downgrades highlight deepening concerns over earnings estimate revisions and the companies' heavy exposure to a cooling Chinese economy. Full story: https://getfinancebrief.com/story/zacks-downgrades-fortescue-kering-strong-sell --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.